FAQ: Capitalization and amortization of R&D costs under new Section 174 rules

Middle market companies engaging in research and development activities face new challenges due to new Section 174 rules. The required capitalization and amortization of R&D costs is problematic and confusing for many businesses, especially those in the technology and life sciences sectors.

Find answers here to some of the most frequently asked questions about the new rules and their ramifications, such as identification and treatment of R&D expenses, software development, state and local tax, international tax, legislative processes, administrative guidance, and advocacy.

Read the full article here

KraftCPAs can help.

Call us at 615-242-7351 or complete the form below to connect with an advisor.

  • Should be Empty:
  • Topic Name:

Search Site

Search Team

Search Articles